IP Library Granted Patent US 10,517,891
Granted Patent B2
US 10,517,891 · App. 15/107,570 · Granted Dec 31, 2019

Maternal vitamin B12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers

Inventors: Cyrus Cooper (Southampton Hampshire, GB); Peter David Gluckman (Auckland, NZ); Keith Malcolm Godfrey (Ashurst Hampshire, GB); Catherine Mace (Lausanne, CH); Irma Silva Zolezzi (Carrouge, CH)
Assignee: Societe des Produits Nestle S.A.
A61K31/714A23L33/15A23L33/30A23L33/40A61K9/0095A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,517,891
App. No.
15/107,570
Granted
Dec 31, 2019
Kind
B2
Abstract

The present invention generally relates to the early prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children. For example, the present invention relates to the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in infants or children through appropriate nutrition for women desiring to get pregnant and/or during pregnancy and/or lactation. Embodiments of the present invention relate to vitamin B12 for use in the prevention of overweight, obesity, excessive fat accumulation and/or associated metabolic disorders in the offspring, wherein the vitamin B12 is administered to an overweight and/or obese women desiring to get pregnant and/or to the overweight and/or obese mother during pregnancy and/or lactation and to maternal food compositions that can be used for this purpose.

Claims (15)

1. A method for inhibiting or reducing the incidence of obesity and/or metabolic disorders associated the in the offspring of an overweight and/or obese mother, the method comprising administering a maternal food composition comprising vitamin B12 to the overweight and/or obese mother before pregnancy, during pregnancy and/or during lactation, wherein the maternal food composition is made by reconstituting a powdered nutritional formula in milk or water, the powdered nutritional formula comprising a protein source, a carbohydrate source, a lipid source, lecithin, bulking agents and 0.18-18.2 μg of the vitamin B12/100 g dry weight of the powdered nutritional formula.

2. The method of claim 1 , wherein the vitamin B12 is administered to the overweight and/or obese mother in an amount corresponding to 0.26-26 μg vitamin B12/day.

3. The method of claim 1 , wherein the vitamin B12 is administered to the overweight and/or obese mother for at least 4 consecutive weeks before pregnancy, during pregnancy and/or during lactation.

4. The method of claim 1 , wherein the vitamin B12 is administered to the overweight and/or obese mother at least once daily.

5. The method of claim 1 , wherein the vitamin B12 is provided from natural sources.

6. The method of claim 1 , wherein the composition inhibits or reduces the incidence of obesity and/or associated metabolic disorders in the offspring later in life.

7. The method of claim 6 , wherein the composition inhibits or reduces the incidence of obesity in the offspring at the age of at least 3 years.

8. The method of claim 1 , wherein the composition inhibits or reduces the incidence of obesity by reducing fat mass.

9. The method of claim 1 , wherein the method inhibits or reduces both the incidence of obesity and metabolic disorders associated with obesity in the offspring.

10. The method of claim 1 , wherein the metabolic disorders are selected from the group consisting of diabetes, cardiovascular diseases, hypertension, and combinations thereof.

11. The method of claim 1 , wherein the metabolic disorders are selected from the group consisting of cardiovascular diseases, hypertension, and combinations thereof.

12. The method of claim 1 , wherein the mother is obese.

13. The method of claim 1 , wherein the powdered nutritional formula further comprises at least one component selected from the group consisting of probiotic bacteria, folic acid, calcium, iron, arachidonic acid (ARA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

14. The method of claim 1 , wherein the protein source comprises at least one of dried milk or dried skimmed milk, the carbohydrate source comprises at least one of sucrose or mailtodextrin, and the lipid source comprises vegetable oil.

15. The method of claim 1 , wherein a daily dose of the powdered nutritional formula further comprises at least one micronutrient selected from the group consisting of: 100 to 2500 mg calcium, 35 to 350 mg magnesium, 70 to 3500 mg phosphorus, 2.7 to 45 mg iron, 1.1 to 40 mg zinc, 0.1 to 10 mg copper, 22 to 1.100 μg iodine; 6 to 400 μg selenium, 77 to 3000 μg of vitamin A or retinol activity equivalent, 8.5 to 850 mg Vitamin C, 0.14 to 14 mg Vitamin B1, 0.14 to 14 mg Vitamin B2, 1.8 to 35 mg niacin, 0.19 to 19 μg Vitamin B6, 60 to 1000 μg folic acid, 3 to 300 μg biotin; 1.5 to 100 μg Vitamin D, and 1.9 to 109 μg Vitamin E.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: COOPER, CYRUS; GLUCKMAN, PETER DAVID; GODFREY, KEITH MALCOLM; MACE, CATHERINE; SILVA ZOLEZZI, IRMA
To: NESTEC S.A.
Reel/Frame 043133/0023 →
Priority Claims (2)
EP 14150793 · Jan 10, 2014 · regional
EP 14161184 · Mar 21, 2014 · regional
Continuity (1)
Related Publication 20160317565A1 · Nov 3, 2016